FDA — authorised 25 August 2011
- Marketing authorisation holder: SHIRE ORPHAN THERAP
- Status: approved
🇺🇸 Firazyr in United States
FDA authorised Firazyr on 25 August 2011
Marketing authorisation
Firazyr in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Firazyr approved in United States?
Yes. FDA authorised it on 25 August 2011.
Who is the marketing authorisation holder for Firazyr in United States?
SHIRE ORPHAN THERAP holds the US marketing authorisation.